Pfizer, Astellas deal
The pharmas agreed to terminate on March 31, 2015, a 2009 deal to co-commercialize Caduet amlodipine besylate/atorvastatin for hypertension and hypercholesterolemia in Japan. Pfizer will be responsible for sole promotion of the product from Oct....